Clinical Use of Cocaine: A Review of the Risks and Benefits
Middleton, Robert M.
Kirkpatrick, Michael B.
Drug Safety 1993 September; 9(3): 212-217
Showing items related by title, author, creator and subject.
Evaluating the Risks and Benefits of Phase II and III Clinical Cancer Trials: A Look at Institutional Review Board Members in the Netherlands van Luijn, H.E.M.; Musschenga, A.W.; Keus, R.B.; Aaronson, N.K. (2007-01)
The Evaluation of the Risks and Benefits of Phase II Cancer Clinical Trials by Institutional Review Boards (IRB) Members: A Case Study van Luijn, H.E.M.; Aaronson, N.K.; Keus, R.B.; Musschenga, A.W. (2006-03)There are indications that institutional review board (IRB) members do not find it easy to assess the risks and benefits in medical experiments, although this is their principal duty. This study examined how IRB members ...
Increasing Burden of Institutional Review in Multicenter Clinical Trials of Infertility: The Reproductive Medicine Network Experience With the Pregnancy in Polycystic Ovary Syndrome (PPCOS) I and II Studies Schlaff, William D; Zhang, Heping; Diamond, Michael P; Coutifaris, Christos; Casson, Peter R; Brzyski, Robert G; Christman, Gregory M; Barnhart, Kurt T; Trussell, J C; Krawetz, Stephen A; Snyder, Peter J; Ohl, Dana; Santoro, Nanette; Eisenberg, Esther; Huang, Hao; Legro, Richard S (Reproductive Medicine Network, 2011-07)Many clinical investigators think that the burden of Institutional Review Board (IRB) requirements has been consistently increasing over recent years, although there are few objective data describing these trends. Over a ...